MYOMO (MYO) Chief Medical Officer disposes shares to cover RSU tax

Rhea-AI Filing Summary

MYOMO, INC. Chief Medical Officer Harry Kovelman reported a routine tax-related share disposition. On June 8, 2026, 7,635 shares of common stock were sold at $1.33 per share solely to cover income taxes from restricted stock units that vested on June 5, 2026. After this transaction, he directly holds 100,983 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kovelman Harry

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	7,635	$1.33	$10K

Holdings After Transaction: Common Stock — 100,983 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withholding shares: 7,635 shares Transaction price: $1.33 per share Post-transaction holdings: 100,983 shares +3 more

6 metrics

Tax-withholding shares 7,635 shares Common stock disposed June 8, 2026 to pay income taxes

Transaction price $1.33 per share Price for tax-withholding disposition on June 8, 2026

Post-transaction holdings 100,983 shares Common stock directly held after the Form 4 transaction

Tax-withholding value $10,155.55 7,635 shares at $1.33 per share used for tax payment

Vesting date June 5, 2026 Restricted stock units that triggered the tax liability vested

Transaction date June 8, 2026 Date shares were disposed to satisfy income tax obligations

Key Terms

restricted stock units, tax-withholding disposition, Form 4, Chief Medical Officer

4 terms

restricted stock units financial

"resulting from a vesting of restrcted stock units on June 5, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax-withholding disposition financial

"transaction_action: tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Chief Medical Officer financial

"officer_title: Chief Medical Officer"

A chief medical officer is a senior executive responsible for overseeing the health and medical strategies within an organization, often in the healthcare or pharmaceutical sectors. They play a key role in guiding decisions related to medical research, product safety, and healthcare policies, which can impact a company's reputation and success. For investors, understanding the chief medical officer's role helps gauge how well a company manages medical risks and advances its healthcare goals.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kovelman Harry

(Last) (First) (Middle)

C/O MYOMO, INC.

45 BLUE SKY DR., SUITE 101

(Street)

BURLINGTON MASSACHUSETTS 01803

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MYOMO, INC. [ MYO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/08/2026		F		7,635(1)	D	$1.33	100,983	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold on June 8, 2026 solely to pay income taxes resulting from a vesting of restrcted stock units on June 5, 2026.

	/s/ David A. Henry, Attorney-in-Fact	06/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MYOMO (MYO) report for Harry Kovelman?

MYOMO reported that Chief Medical Officer Harry Kovelman disposed of 7,635 common shares. The shares were used solely to cover income taxes triggered by restricted stock units vesting, rather than representing an open-market investment decision or discretionary sale.

Was the MYO insider transaction an open-market sale or tax withholding?

The transaction was a tax-withholding disposition, not an open-market sale. Shares were sold on June 8, 2026 to pay income taxes arising from restricted stock units that vested on June 5, 2026, according to the filing’s explanatory footnote.

How many MYOMO (MYO) shares does Harry Kovelman hold after this Form 4?

After the reported tax-withholding transaction, Chief Medical Officer Harry Kovelman directly holds 100,983 shares of MYOMO common stock. This figure reflects his position following the 7,635-share disposition used to satisfy income tax obligations related to vested restricted stock units.

At what price were the MYO shares disposed of in the tax transaction?

The 7,635 MYOMO common shares were disposed of at a price of $1.33 per share. This price applies to the tax-withholding transaction that covered income taxes due from the vesting of restricted stock units occurring three days earlier, on June 5, 2026.

What triggered the tax liability leading to MYO’s insider share disposition?

The tax liability came from the vesting of restricted stock units on June 5, 2026. To satisfy the resulting income taxes, 7,635 shares of MYOMO common stock were sold on June 8, 2026, as described in the Form 4 footnote accompanying the transaction.